Sinco Pharmaceuticals Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
107.00
110.00
115.00
201.00
152.00
48.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-352.00
270.00
-6.00
169.00
-5.00
-84.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-269.00
375.00
67.00
342.00
147.00
-23.00
Cash Flow from Investing Activities
-57.00
-70.00
-140.00
-28.00
-53.00
-2.00
Cash Flow from Financing Activities
185.00
-194.00
123.00
-90.00
-183.00
189.00
Net Cash Inflow / Outflow
-140.00
120.00
65.00
219.00
-91.00
163.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
9.00
14.00
-4.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sinco Pharmaceuticals Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
107.251422500534
82.858554492206
25.00
29.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-352.668741922931
55.7616322202266
-407.00
-732.46%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-269.930536277578
142.618804243605
-411.00
-289.27%
Cash Flow from Investing Activities
-57.5451804409205
-37.8253171936038
-20.00
-52.13%
Cash Flow from Financing Activities
185.266749087938
-39.1198804615593
224.00
573.59%
Net Cash Inflow / Outflow
-140.517578436254
66.8109573992336
-206.00
-310.32%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.69138919430685
1.13735081079171
0.00
48.71%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -171.91% vs 453.70% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-269.93
375.40
-171.91%






